$CRDF
Cardiff Oncology, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.896
▼-0.57%-$0.005
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCardiff Oncology, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CRDF down today? It is at $0.896 (-0.57%), and our scanner flagged it 31 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CRDF spikes, and full due diligence on CRDF — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CRDF 31 times in the last 30 days. Create a free account to track $CRDF, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CRDF from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CRDF today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Across every filing on file, supply equal to 37.8% of the tradeable float is in play - 37.8% has already been sold.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
18,329,161 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mohindru Mani Officer | Bought (open market) | +34K 0.04% of company | added 100% | 59K | $50K at $1.46 | Jul 14, 26 |
Pace Gary W Director | Bought (open market) | +687K 0.9% of company | added 51% | 2.04M | $1.0M at $1.46 | Jul 14, 26 |
Mohindru Mani Officer | Bought (open market) | +25K 0.03% of company | n/a | 25K | $30K at $1.21 | Jun 18, 26 |
Pace Gary W Director | Bought (open market) | +30K 0.04% of company | added 2.3% | 1.36M | $37K at $1.22 | Jun 18, 26 |
Pace Gary W Director | Bought (open market) | +275K 0.4% of company | added 26% | 1.33M | $674K at $2.45 | Jul 30, 25 |
Pace Gary W Director | Bought (open market) | +15K 0.02% of company | added 1.1% | 1.35M | $37K at $2.45 | Jul 30, 25 |
Levine James E. Officer | Bought (open market) | +2K | added 3.7% | 68K | $12K at $5.00 | Dec 18, 24 |
Levine James E. Officer | Bought (open market) | +3K | added 4.4% | 65K | $15K at $5.42 | Dec 17, 24 |
Levine James E. Officer | Bought (open market) | +3K | added 4.3% | 63K | $10K at $3.83 | Dec 16, 24 |
Tannenbaum Renee P Director | Bought (open market) | +10K 0.01% of company | added 100% | 20K | $34K at $3.42 | Dec 12, 24 |
Pace Gary W Director | Bought (open market) | +350K 0.5% of company | added 50% | 1.05M | $910K at $2.60 | Dec 11, 24 |
Pace Gary W Director | Bought (open market) | +12K 0.01% of company | added 1.1% | 1.06M | $30K at $2.60 | Dec 11, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CRDF from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CRDF today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CRDF last traded at $0.896, down 0.57% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Cardiff Oncology, Inc. Common Stock (CRDF) is next expected to report earnings on Thursday, November 5, 2026, about 17 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CRDF Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CRDF 31 times in the last 30 days.
CRDF (Cardiff Oncology, Inc. Common Stock) trades on XNAS, with a market cap of about $70M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CRDF for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CRDF discussion
Sign in to ask a question or join the discussion.